Funding

[Funding alert] Berlin-based Myosotis Raises €8Million in Series A Round Funding

Feb 1, 2024 | By Team SR

Berlin-based Myosotis raises €8million in series A round funding from TVM Capital Life Science.Myosotis, also referred to as myo, was established in 2018 with the goal of relieving care home personnel using digital solutions and enhancing industry transparency, engagement, and appreciation.

Berlin-based Myosotis raises €8million in series A round funding from TVM Capital Life Science.Myosotis, also referred to as myo, was established in 2018 with the goal of relieving care home personnel using digital solutions and enhancing industry transparency, engagement, and appreciation.

It created an app that facilitates rapid, simple, and digital communication between care facilities, families, and service providers. In addition to conducting video conversations, families can get and view papers, photos, and videos of their loved ones.

Read also -  Netherlands-based Tidal Control Secures €500K in a Pre-Seed Round Funding

Other software features streamline time-consuming but crucial administrative duties like food ordering, tracking complaints, and overseeing essential outside services like pharmacies and laundromats. This enhances documentation while saving time and money.

Dr. Sascha Berger, General Partner of TVM Capital Life Science, commented: "At TVM, we are committed to advancing healthcare innovations that address unmet needs. Digital tools offer the promise of significantly increasing the efficiency of the healthcare system and giving medical professionals more time to do what they do best – care for their patients.myo's unique approach to elderly care communication could transform this crucial and growing sector, contributing to improved communication amongst healthcare staff, relatives and service providers, resulting in better care."

Jasper Böckel, CEO of myo, added: "This funding is an important step in our growth plan. We are delighted to have such a well-regarded investor as TVM come on board and look forward to leveraging their experience with commercial-stage life science companies. Our passionate team is dedicated to enhancing human interactions in care settings, and these proceeds will now enable us to roll out our technology to more users and develop additional solutions for healthcare providers and families."

This will entail creating new modules, improving the level of service provided to current clients, and increasing marketing capability. The myo Board of Directors will welcome Dr. Sascha Berger, General Partner, and Stefan Fischer, Managing Partner (Finance), from TVM.

Read also - Limburg-based Foodtech Company Verdify Raises €2.4Million in Funding

About Myosotis

myo is a cutting-edge communication tool for the caregiver industry. Care providers can interact with family members in a direct, secure, and professional manner by using myo. Through text or voice messages, images, videos, and medical or organizational updates, caregivers can record and distribute information on field trips.

Read also - Amsterdam-based Send AI Raises €2.2Million in a Pre-Seed Round Funding

Recommended Stories for You